Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database

Bertram, Lars, McQueen, Matthew B, Mullin, Kristina, Blacker, Deborah, Tanzi, Rudolph E·2007·Nature Genetics
DOI 10.1038/ng1934

Cited by (1,006)

Items 701–800 of 1,006

  1. MaxLink: network-based prioritization of genes tightly linked to a disease seed set
    Dimitri Guala, Erik Sjölund, Erik L. L. Sonnhammer · 2014 · Bioinformatics
  2. Partial least squares correspondence analysis: A framework to simultaneously analyze behavioral and genetic data.
    Derek Beaton, Alzheimer’s Disease Neuroimaging Initiative, Joseph P. Dunlop, Hervé Abdi · 2015 · Psychological Methods
  3. Altered gene expression in late-onset Alzheimer's disease due to SNPs within 3′UTR microRNA response elements
    Jyoti Roy, Bibekanand Mallick · 2017 · Genomics
  4. Loss of Neuroprotective Factors in Neurodegenerative Dementias: The End or the Starting Point?
    Luisa Benussi, Giuliano Gb. Binetti, Roberta Ghidoni · 2017 · Frontiers in Neuroscience
  5. Combining phenome-driven drug-target interaction prediction with patients’ electronic health records-based clinical corroboration toward drug discovery
    Mengshi Zhou, Chunlei Zheng, Rong Xu · 2020 · Bioinformatics
  6. Association study of the GAB2 gene with the risk of developing Alzheimer's disease
    Julien Chapuis, Didier Hannequin, Florence Pasquier, Peter Bentham, Alexis Brice, Isabelle Le Ber, Thierry Frébourg, Jean‐François Deleuze, Emmanuelle Cousin, Uma Thaker et al. · 2008 · Neurobiology of Disease
  7. A Drastic Reduction in the Life Span of Cystatin C L68Q Carriers Due to Life-Style Changes during the Last Two Centuries
    Ástríður Pálsdóttir, Agnar Helgason, Snæbjörn Pálsson, Hans Tomas Bjornsson, Birkir Þór Bragason, Sólveig Grétarsdóttir, Unnur Þorsteinsdóttir, Elías Ólafsson, Kāri Stefánsson · 2008 · PLoS Genetics
  8. Corticosteroid receptor genes and childhood neglect influence susceptibility to crack/cocaine addiction and response to detoxification treatment
    Diego Luiz Rovaris, Nina Roth Mota, Guilherme Pinto Bertuzzi, Angelita P. Aroche, Sidia Maria Callegari-Jacques, Luciano Santos Pinto Guimarães, Júlio Carlos Pezzi, Thiago Wendt Viola, Claiton H.D. Bau, Rodrigo Grassi‐Oliveira · 2015 · Journal of Psychiatric Research
  9. Advances in the genetics of Parkinson's disease
    Serena Rosner, Nir Giladi, Avi Orr‐Urtreger · 2008 · Acta Pharmacologica Sinica
  10. Genetic Variation of CYP19 (Aromatase) Gene Influences Age at Onset of Alzheimer’s Disease in Women
    Rosa Maria Corbo, Giuseppe Gambina, Laura Ulizzi, Giuseppe Moretto, Renato Scacchi · 2009 · Dementia and Geriatric Cognitive Disorders
  11. A Multi-Center Study of ACE and the Risk of Late-Onset Alzheimer's Disease
    Belbin, Olivia, Brown, Kristelle, Shi, Hui, Medway, Christopher, Abraham, Richard, Passmore, Peter, Mann, David, Smith, A. David, Holmes, Clive, McGuinness, Bernadette et al. · 2011 · Journal of Alzheimer's Disease
  12. Lower DNA methylation levels in CpG island shores of CR1, CLU, and PICALM in the blood of Japanese Alzheimer’s disease patients
    Mitsumori, Risa, Sakaguchi, Kazuya, Shigemizu, Daichi, Mori, Taiki, Akiyama, Shintaro, Ozaki, Kouichi, Niida, Shumpei, Shimoda, Nobuyoshi · 2020 · PLOS ONE
  13. Promising Genetic Biomarkers of Preclinical Alzheimer's Disease: The Influence ofAPOEandTOMM40on Brain Integrity
    Beata Ferencz, Sari Karlsson, Grégoria Kalpouzos · 2012 · International Journal of Alzheimer s Disease
  14. Envelhecimento e longevidade no Rio Grande do Sul: um perfil histórico, étnico e de morbi-mortalidade dos idosos
    Maria Gabriela Valle Gottlieb, Carla Helena Augustin Schwanke, Irênio Gomes, Ivana Beatrice Mânica da Cruz · 2011 · Revista Brasileira de Geriatria e Gerontologia
  15. Association of Parkinson’s Disease GWAS-Linked Loci with Alzheimer’s Disease in Han Chinese
    Xi‐Chen Zhu, Lei Cao, Meng‐Shan Tan, Teng Jiang, Hui-Fu Wang, Huan Lu, Chen‐Chen Tan, Wei Zhang, Lan Tan, Jin‐Tai Yu · 2016 · Molecular Neurobiology
  16. Genetic Modifiers in Neurodegeneration
    Nimansha Jain, Alice S. Chen‐Plotkin · 2018 · Current Genetic Medicine Reports
  17. Systematic review of genetic association studies in people with Lewy body dementia
    Hazel Sanghvi, Ricky Singh, Hamilton Morrin, Anto Praveen Rajkumar · 2020 · International Journal of Geriatric Psychiatry
  18. To Know or Not to Know: An Update of the Literature on the Psychological and Behavioral Impact of Genetic Testing for Alzheimer Disease Risk
    Belinda Rahman, Bettina Meiser, Perminder Singh Sachdev, Kristine K Barlow-Stewart, Margaret F. A. Otlowski, Elvira M. Zilliacus, Peter R. Schofield · 2012 · Genetic Testing and Molecular Biomarkers
  19. Schizophrenia and vitamin D related genes could have been subject to latitude-driven adaptation
    Roberto Amato, Michele Pinelli, Antonella Monticelli, Gennaro Miele, Sergio Cocozza · 2010 · BMC Evolutionary Biology
  20. Angiotensins and Alzheimer's disease: a bench to bedside overview
    Patrick G. Kehoe · 2009 · Alzheimer s Research & Therapy
  21. Cysteine 27 Variant of the δ-Opioid Receptor Affects Amyloid Precursor Protein Processing through Altered Endocytic Trafficking
    Timo Sarajärvi, Jussi T. Tuusa, Annakaisa Haapasalo, Jarkko J. Lackman, Raija T. Sormunen, Seppo Helisalmi, Johannes T. Roehr, Antonio Parrado, Petra M. Mäkinen, Lars Bertram et al. · 2011 · Molecular and Cellular Biology
  22. The ONDRISeq panel: custom-designed next-generation sequencing of genes related to neurodegeneration
    Sali M.K. Farhan, Allison Ann Dilliott, Mahdi Ghani, Christine Sato, Eric Liang, Ming Zhang, Adam D. McIntyre, Henian Cao, Lemuel Racacho, John F. Robinson et al. · 2016 · npj Genomic Medicine
  23. A human carboxypeptidase E/NF-α1 gene mutation in an Alzheimer’s disease patient leads to dementia and depression in mice
    Yong Cheng, Niamh X. Cawley, Tülin Yanık, Saravana R. K. Murthy, C Liu, F Kasikci, Daniel T. Abebe, Y. Peng Loh · 2016 · Translational Psychiatry
  24. Gene expression levels as endophenotypes in genome-wide association studies of Alzheimer disease
    F. Zou, Minerva M. Carrasquillo, V. Shane Pankratz, Olivia Belbin, Kevin Morgan, Mariet Allen, Samantha L. Wilcox, Li Ma, Louise P. Walker, Naomi Kouri et al. · 2010 · Neurology
  25. EnigmaVis: Online Interactive Visualization of Genome-Wide Association Studies of the Enhancing NeuroImaging Genetics through Meta-Analysis (ENIGMA) Consortium
    Nic M. Novak, Jason L. Stein, Sarah Elizabeth Medland, Derrek P. Hibar, Paul M. Thompson, Arthur W. Toga · 2012 · Twin Research and Human Genetics
  26. The association between neighborhood socioeconomic status, cardiovascular and cerebrovascular risk factors, and cognitive decline in the Health and Retirement Study (HRS)
    Maragatha N. Kuchibhatla, Jaimie C. Hunter, Brenda L. Plassman, Michael William Lutz, Ramon Casanova, Santiago J. Saldana, Kathleen M. Hayden · 2019 · Aging & Mental Health
  27. Cholesterol and Dementia: A Long and Complicated Relationship
    Oliwia McFarlane, Kornelia Kędziora–Kornatowska · 2019 · Current Aging Science
  28. The influence of ApoE4 on clinical progression of dementia: a meta-analysis
    Charlotte L. Allan, Klaus P. Ebmeier · 2010 · International Journal of Geriatric Psychiatry
  29. Low Plasma ApoE Levels Are Associated with Smaller Hippocampal Size in the Alzheimer's Disease Neuroimaging Initiative Cohort
    Edmond Teng, Nicole Chow, Kristy Hwang, Paul M. Thompson, Karen H. Gylys, Gregory M. Cole, Clifford R. Jack, Leslie M. J. Shaw, John Q. Trojanowski, Holly D Soares et al. · 2014 · Dementia and Geriatric Cognitive Disorders
  30. Cystatin C in macular and neuronal degenerations: Implications for mechanism(s) of age-related macular degeneration
    Luminita Paraoan, Paul Stephenson Hiscott, Christine M Gosden, Ian Grierson · 2009 · Vision Research
  31. Rejoinder
    Eric J. Tchetgen Tchetgen, M. Maria Glymour, Ilya Shpitser, Jennifer Weuve · 2011 · Epidemiology
  32. A Validation Study of Vascular Cognitive Impairment Genetics Meta-Analysis Findings in an Independent Collaborative Cohort
    Olivia Anna Skrobot, Amy Jayne McKnight, Peter Passmore, Davide Seripa, Patrizia Mecocci, Francesco Panza, Raj N. Kalaria, Gordon Keith Wilcock, Marcus Robert Munafo, Timo Erkinjuntti et al. · 2016 · Journal of Alzheimer s Disease
  33. The latest suspect
    Rudolph E. Tanzi, Lars Bertram · 2008 · Nature
  34. Interleukin 6–174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease
    Cristiano A. Capurso, Vincenzo Solfrizzi, Anna Maria Colacicco, Alessia D’Introno, Vincenza Frisardi, Bruno Pietro Imbimbo, Maria Lorusso, Gianluigi Vendemiale, Marta Denitto, Andrea Santamato et al. · 2009 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  35. The FAS gene, brain volume, and disease progression in Alzheimer's disease
    Deniz Erten‐Lyons, Anne Jacobson, Patricia Kramer, Andrew Grupe, Jeffrey Alan Kaye · 2009 · Alzheimer s & Dementia
  36. Biomarkers for Alzheimer’s disease
    Malcolm Andrew Ward · 2007 · Expert Review of Molecular Diagnostics
  37. Cystatin C Levels are Positively Correlated with both Aβ42 and Tau Levels in Cerebrospinal Fluid in Persons with Alzheimer's Disease, Mild Cognitive Impairment, and Healthy Controls
    Sundelöf, Johan, Sundström, Johan, Hansson, Oskar, Eriksdotter-Jönhagen, Maria, Giedraitis, Vilmantas, Larsson, Anders, Degerman-Gunnarsson, Malin, Ingelsson, Martin, Minthon, Lennart, Blennow, Kaj et al. · 2010 · Journal of Alzheimer's Disease
  38. Genome‐wide linkage analyses of non‐Hispanic white families identify novel loci for familial late‐onset Alzheimer's disease
    Kunkle, Brian W., Jaworski, James, Barral, Sandra, Vardarajan, Badri, Beecham, Gary W., Martin, Eden R., Cantwell, Laura S., Partch, Amanda, Bird, Thomas D., Raskind, Wendy H. et al. · 2016 · Alzheimer's & Dementia
  39. Male-specific epistasis between WWC1 and TLN2 genes is associated with Alzheimer's disease
    Gusareva, Elena S., Twizere, Jean-Claude, Sleegers, Kristel, Dourlen, Pierre, Abisambra, Jose F., Meier, Shelby, Cloyd, Ryan, Weiss, Blaine, Dermaut, Bart, Bessonov, Kyrylo et al. · 2018 · Neurobiology of Aging
  40. NeuroDNet - an open source platform for constructing and analyzing neurodegenerative disease networks
    Suhas V. Vasaikar, Aditya Kumar Padhi, Bhyravabhotla Jayaram, James Gomes · 2013 · BMC Neuroscience
  41. Expanding the cerebrospinal fluid endopeptidome
    Karl T. Hansson, Tobias Borgh Skillbäck, Elin Pernevik, Silke Kern, Erik Portelius, Kina Höglund, Gunnar Brinkmalm, Jessica Holmén‐Larsson, Kaj Blennow, Henrik Zetterberg et al. · 2017 · PROTEOMICS
  42. Advance genome editing technologies in the treatment of human diseases: CRISPR therapy (Review)
    Meryem Alagöz, Nasim Kherad · 2020 · International Journal of Molecular Medicine
  43. Influence of apolipoprotein-E genotype on brain amyloid load and longitudinal trajectories
    Brian J. Lopresti, Elizabeth M. Campbell, Zheming Yu, Stewart Anderson, Ann D. Cohen, Davneet Singh Minhas, Beth Ellen Snitz, Sarah K. Royse, Carl R Becker, Howard Jay Aizenstein et al. · 2020 · Neurobiology of Aging
  44. Correlation between Alzheimer’s disease and type 2 diabetes using non-negative matrix factorization
    Yeonwoo Chung, Hyunju Lee, the Alzheimer’s Disease Neuroimaging Initiative, Michael Walter Weiner, Paul S. S. Aisen, Ronald Carl Petersen, Cliford R. Jack, William J. Jagust, John Q. Trojanowki, Arthur W. Toga et al. · 2021 · Scientific Reports
  45. Data-driven causal model discovery and personalized prediction in Alzheimer's disease
    Haoyang Zheng, Jeffrey R. Petrella, Pudugramam Murali Doraiswamy, Guang Lin, Wenrui Hao, Alzheimer’s Disease Neuroimaging Initiative · 2022 · npj Digital Medicine
  46. PLA2G3, a Gene Involved in Oxidative Stress Induced Death, is Associated with Alzheimer's Disease
    Ana Martı́nez-Garcı́a, Isabel Sastre, Marı́a Recuero, Jesús Aldudo, Elisabet Vilella, Ignacio Mateo, Pascual Sánchez‐Juan, Teodoro Vargas, Eva Carro, Félix Bermejo‐Pareja et al. · 2011 · Journal of Alzheimer s Disease
  47. Opportunities in pharmacogenomics for the treatment of Alzheimer’s disease
    Ramón Cacabelos, Clara Torrellas, Iván Carrera · 2015 · Future Neurology
  48. Estimating and disclosing the risk of developing Alzheimer‘s disease: challenges, controversies and future directions
    Jeffrey Scott Roberts, Sarah M Tersegno · 2010 · Future Neurology
  49. CLU Genetic Variants and Cognitive Decline among Elderly and Oldest Old
    Jonas Mengel‐From, Mikael Thinggaard, Rune Lindahl‐Jacobsen, Matt K. McGue, Kaare Christensen, Lene Christiansen · 2013 · PLoS ONE
  50. Genetic aspects of behavioral neurotoxicology
    Edward D. Levin, Michael Aschner, Ulrike Heberlein, Douglas Mark Ruden, Kathleen Anne Welsh-Bohmer, Selena E. Bartlett, Karen H. Berger, Lang Chen, Ammon B. Corl, Donnie M. Eddins et al. · 2009 · NeuroToxicology
  51. Involvement of paraoxonase 1 genetic variants in Alzheimer’s disease neuropathology
    Valérie Leduc, Louise Théroux, Doris Dea, Yves Robitaille, Judes Poirier · 2009 · European Journal of Neuroscience
  52. A single nucleotide polymorphism in LRP2 is associated with susceptibility to Alzheimer's disease in the Chinese population
    Liling Wang, Xiaoling Pan, Ying Wang, Huidong Tang, Yulei Deng, Ru‐Jing Ren, Wei Lin Xu, Jianfang Ma, Gang Wang, Shengdi Chen · 2010 · Clinica Chimica Acta
  53. A combined effect of two Alzheimer's risk genes on medial temporal activity during executive attention in young adults
    Adam E. Green, Jeremy R. Gray, Colin G. DeYoung, Timothy R. Mhyre, Robert M. Padilla, Amanda Marie DiBattista, George William Rebeck · 2014 · Neuropsychologia
  54. ApoE and pulse pressure interactively influence level and change in the aging of episodic memory: Protective effects among ε2 carriers.
    G. Peggy McFall, Sandra A. Wiebe, David Vergote, David A. Westaway, Jack H. Jhamandas, Lars Bäckman, Roger A. Dixon · 2014 · Neuropsychology
  55. Genetic Analyses of Alzheimer’s Disease in China: Achievements and Perspectives
    Dengfeng Zhang, Min Xu, Rui Bi, Yong‐Gang Yao · 2019 · ACS Chemical Neuroscience
  56. Plasma Angiotensin-Converting Enzyme in Alzheimer's Disease
    Emma R. L. C. Vardy, Penny J. Rice, Peter C. W. Bowie, John D. Holmes, Andrew J. Catto, Nigel M. Hooper · 2009 · Journal of Alzheimer s Disease
  57. TOMM40 Association With Alzheimer Disease
    Rita João Guerreiro, John Hardy · 2012 · Archives of Neurology
  58. Limits to forecasting in personalized medicine: An overview
    John P. A. Ioannidis · 2009 · International Journal of Forecasting
  59. Disrupted topology of the resting state structural connectome in middle-aged APOE ε4 carriers
    Laura Elizabeth Korthauer, L. Zhan, Olusola Ajilore, Alex Leow, Ira Frahmand Driscoll · 2018 · NeuroImage
  60. Clinical implications of APOE genotyping for late-onset Alzheimer’s disease (LOAD) risk estimation: a review of the literature
    Victoria S. Marshe, Ilona Gorbovskaya, Sarah Kanji, Maxine Kish, Daniel J. Müller · 2018 · Journal of Neural Transmission
  61. Genetic mutations of APOEε4 carriers in cardiovascular patients lead to the development of insulin resistance and risk of Alzheimer's disease
    Komal Jabeen, Kanwal Rehman, Muhammad Sajid Hamid Akash · 2021 · Journal of Biochemical and Molecular Toxicology
  62. Influence of COMT Val158Met Polymorphism on Alzheimer's Disease and Mild Cognitive Impairment in Italian Patients
    Cristina Lanni, Giulia Garbin, Antonella Lisa, Fabrizio Biundo, Alberto Ranzenigo, Elena Sinforiani, Giovanni Cuzzoni, Stefano M. Govoni, Guglielmina Nadia Ranzani, Marco Racchi · 2012 · Journal of Alzheimer s Disease
  63. Dementia and Alzheimer's disease: A new direction. The 2010 Jay L. Foster Memorial Lecture
    Lewis H. Kuller, Oscar L. López · 2011 · Alzheimer s & Dementia
  64. Children of Persons With Alzheimer Disease
    Lissy F. Jarvik, Asenath A. LaRue, Deborah Blacker, Margaret Gatz, Claudia H. Kawas, John J. McArdle, John C. Morris, James A. Mortimer, John Matthew Ringman, Linda M. Ercoli et al. · 2008 · Alzheimer Disease & Associated Disorders
  65. Power and Pitfalls of the Genome-Wide Association Study Approach to Identify Genes for Alzheimer’s Disease
    Richard Sherva, Lindsay A. Farrer · 2011 · Current Psychiatry Reports
  66. Metal attenuating therapies in neurodegenerative disease
    Alexandra I. Mot, Anthony G. Wedd, Layla Sinclair, David R. Brown, Steven John Collins, Marcus W. Brazier · 2011 · Expert Review of Neurotherapeutics
  67. Hippocampal Surface Mapping of Genetic Risk Factors in AD via Sparse Learning Models
    ADNI, Jing Wan, Sungeun Kim, Mark H. Inlow, Kwangsik T. Nho, Shanker Swaminathan, Shannon L. Risacher, Shiaofen Fang, Michael Walter Weiner, Mirza Faisal Beg et al. · 2011 · Lecture notes in computer science
  68. How to Use an Article About Genetic Association
    John Attia, John P. A. Ioannidis, Ammarin Thakkinstian, Mark McEvoy, Rodney J. Scott, Cosetta Minelli, John Russell Thompson, Claire Infante‐Rivard, Gordon Henry Guyatt · 2009
  69. Prion Protein Interactome: Identifying Novel Targets in Slowly and Rapidly Progressive Forms of Alzheimer’s Disease
    Saima Zafar, Mohsin Shafiq, Neelam Younas, Matthias Schmitz, Isidró Ferrer, Inga Zerr · 2017 · Journal of Alzheimer s Disease
  70. Identification of molecular alterations in leukocytes from gene expression profiles of peripheral whole blood of Alzheimer’s disease
    Hongdong Li, Guini Hong, Mengna Lin, Yidan Shi, Lili Wang, Fengle Jiang, Fan Zhang, Yuhang Wang, Zheng Guo · 2017 · Scientific Reports
  71. Viral Induced Oxidative and Inflammatory Response in Alzheimer’s Disease Pathogenesis with Identification of Potential Drug Candidates: A Systematic Review using Systems Biology Approach
    Puneet Talwar, Renu Gupta, Suman S. Kushwaha, Rachna Agarwal, Luciano Saso, Shrikant Kukreti, Ritushree Kukreti · 2018 · Current Neuropharmacology
  72. Precision Medicine for Alzheimer’s Disease Prevention
    Cara L. Berkowitz, Lisa Mosconi, Olivia Scheyer, Aneela Rahman, Hollie Hristov, Richard Isaacson · 2018 · Healthcare
  73. PTCD1 Is Required for Mitochondrial Oxidative-Phosphorylation: Possible Genetic Association with Alzheimer's Disease
    Daniel Fleck, Lilian Phu, Erik Verschueren, Trent B. Hinkle, Mike Reichelt, Tushar Bhangale, Benjamin Haley, Yuanyuan Wang, Robert Graham, Donald S. Kirkpatrick et al. · 2019 · Journal of Neuroscience
  74. Serum homocysteine and risk of dementia in Japan
    Sanmei Chen, Takanori Honda, Tomoyuki Ohara, Jun Hata, Yoichiro Hirakawa, Daigo Yoshida, Mao Shibata, Satoko Sakata, Emi Oishi, Yoshihiko Furuta et al. · 2020 · Journal of Neurology Neurosurgery & Psychiatry
  75. ACE variants and risk of intracerebral hemorrhage recurrence in amyloid angiopathy
    Sophie Domingues‐Montanari, Mar Hernández‐Guillamón, Israel Fernández‐Cadenas, Maite Mendióroz, Merçé Boada, Josep Munuera, Àlex Rovira, Olga Maisterra, Mireia Parés, Maria Gutierrez et al. · 2010 · Neurobiology of Aging
  76. Biomarkers, Dementia, and Public Health
    Caroline Fiona Wright, Alison Hall, Fiona E. Matthews, Carol Brayne · 2009 · Annals of the New York Academy of Sciences
  77. APOE and metabolic dysfunction in Alzheimer's disease
    2020 · International Review of Neurobiology
  78. Preferential interactions between ApoE-containing lipoproteins and Aβ revealed by a detection method that combines size exclusion chromatography with non-reducing gel-shift
    LaDu, Mary Jo, Munson, Gregory W., Jungbauer, Lisa, Getz, Godfrey S., Reardon, Catherine A., Tai, Leon M., Yu, Chunjiang · 2012 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
  79. Emerging and potential therapies for Alzheimer's disease
    Heledd Jarosz-Griffiths, Isobel J. Morten, Nigel M. Hooper · 2008 · Expert Opinion on Therapeutic Targets
  80. Diagnosis of Alzheimer's disease in Brazil: Supplementary exams
    Paulo Caramelli, Antônio Lúcio Teixeira, Carlos Alberto Buchpiguel, Hae Won Lee, JOSÉ ANTONIO LIVRAMENTO, Liana Lisboa Fernandez, Renato Anghinah · 2011 · Dementia & Neuropsychologia
  81. Pharmacogenetics of Vascular Risk Factors in Alzheimer’s Disease
    Ramón Cacabelos, Arun Meyyazhagan, Juan C. Carril, Pablo Cacabelos, Óscar Teijido · 2018 · Journal of Personalized Medicine
  82. Novel Alzheimer’s disease risk variants identified based on whole-genome sequencing of APOE ε4 carriers
    Park, Jong-Ho, Park, Inho, Youm, Emilia Moonkyung, Lee, Sejoon, Park, June-Hee, Lee, Jongan, Lee, Dong Young, Byun, Min Soo, Lee, Jun Ho, Yi, Dahyun et al. · 2021 · Translational Psychiatry
  83. Multiomics Identification of Potential Targets for Alzheimer Disease and Antrocin as a Therapeutic Candidate
    Alexander T.H. Wu, Bashir Lawal, Li Wei, Ya-Ting Wen, David T.W. Tzeng, Wen‐Cheng Lo · 2021 · Pharmaceutics
  84. Gene-Environment Interaction Research and Transgenic Mouse Models of Alzheimer's Disease
    Leonidas Chouliaras, Annerieke S. R. Sierksma, Günter Kenis, Jos Prickaerts, Marijke A.M. Lemmens, Ivona Brasnjevic, Eva L. van Donkelaar, Pilar Martínez‐Martínez, Mario H. Losen, Marc H. De Baets et al. · 2010 · International Journal of Alzheimer s Disease
  85. Clinical and neurochemical correlates of the APOE genotype in early-stage Parkinson’s disease
    Henri Zenuni, Roberta Bovenzi, Jacopo Bissacco, Piergiorgio Grillo, Clara Simonetta, Davide Mascioli, Massimo Pieri, Segio Bernardini, Giulia Maria Sancesario, Alessandro Stefani et al. · 2023 · Neurobiology of Aging
  86. Alzheimer's Disease: The Quest to Understand Complexity
    Sueli Marques, Catarina Resende Oliveira, Tiago F. Outeiro, Cláudia Pereira · 2010 · Journal of Alzheimer s Disease
  87. Retinoic acid as a therapeutic option in Alzheimer’s disease: a focus on cholinergic restoration
    Andrzej Szutowicz, Hanna Bielarczyk, Agnieszka Jankowska-Kulawy, Anna Ronowska, Tadeusz Pawełczyk · 2015 · Expert Review of Neurotherapeutics
  88. Quantification of cystatin C in cerebrospinal fluid from various neurological disorders and correlation with G73A polymorphism in CST3
    Yukiko Yamamoto‐Watanabe, Masao Watanabe, M. T. Jackson, Hiroyuki Akimoto, Kazuhiro Sugimoto, Minoru Yasujima, Yasuhito Wakasaya, Etsuro Matsubara, Takeshi Kawarabayashi, Yasuo Harigaya et al. · 2010 · Brain Research
  89. Estrogen receptor α gene polymorphisms and risk of Alzheimer’s disease: evidence from a meta-analysis
    Cheng Cheng, Bin Liang, Yiwen Hao, Wenling Zhou · 2014 · Clinical Interventions in Aging
  90. Association of anti-inflammatory cytokine IL10 polymorphisms with motoric cognitive risk syndrome in an Ashkenazi Jewish population
    Sanish Sathyan, Nir Barzilai, Gil Atzmon, Sofiya Milman, Emmeline I. Ayers, Joe Verghese · 2017 · Neurobiology of Aging
  91. Evidence for three loci modifying age‐at‐onset of Alzheimer's disease in early‐onset PSEN2 families
    Marchani, Elizabeth E., Bird, Thomas D., Steinbart, Ellen J., Rosenthal, Elisabeth, Yu, Chang‐En, Schellenberg, Gerard D., Wijsman, Ellen M. · 2010 · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
  92. CpG sites with continuously increasing or decreasing methylation from early to late human fetal brain development
    Eberhard Schneider, Marcus T. Dittrich, Julia Böck, Indrajit Nanda, Tobias Müller, Larissa Seidmann, Tim Tralau, Danuta Galetzka, Nady El Hajj, Thomas Haaf · 2016 · Gene
  93. Multiplexing Biomarker Methods, Proteomics and Considerations for Alzheimer’s Disease
    Renã A. S. Robinson, Bushra Amin, Paul C. Guest · 2017 · Advances in experimental medicine and biology
  94. Chinese herbal medicine Qinggongshoutao for the treatment of amnestic mild cognitive impairment: A 52‐week randomized controlled trial
    Jinzhou Tian, Jing Shi, Mingqing Wei, Jingnian Ni, Zhiyong Fang, Jinyu Gao, Heng Wang, Hongjun Yao, Jintao Zhang, Juntao Li et al. · 2019 · Alzheimer s & Dementia Translational Research & Clinical Interventions
  95. Dominantly inherited Alzheimer's disease in Latin America: Genetic heterogeneity and clinical phenotypes
    Jorge J. Llibre‐Guerra, Yan Li, Ricardo Allegri, Patricio Chrem Méndez, Ezequiel Ignacio Surace, Juan J. Llibre Rodríguez, Ana Luisa Sosa, Carmen Aláez‐Verson, Erika Mariana Longoria-Ibarrola, José Alberto Téllez‐Martínez et al. · 2020 · Alzheimer s & Dementia
  96. Age-dependent effect of Alzheimer’s risk variant of CLU on EEG alpha rhythm in non-demented adults
    Н.В. Пономарева, Т. В. Андреева, Maria Protasova, Lev Shagam, Daria D. Malina, Andrei Goltsov, Vitaly Feodor Fokin, Митрофанов Андрей Алексеевич, Evgeny Ivanovich Rogaev · 2013 · Frontiers in Aging Neuroscience
  97. GAB2 gene does not modify the risk of Alzheimer's disease in Spanish APOE 4 carriers
    Reposo Ramírez‐Lorca, Merçé Boada, María Eugenia Sáez, Isabel Hernández, A. Mauleon, Maitée Rosende‐Roca, Pablo Martínez‐Lage, M. Gutierrez, Luís Miguel Real, Jesús López‐Arrieta et al. · 2009 · The journal of nutrition health & aging
  98. Potential Peripheral Biomarkers for the Diagnosis of Alzheimer′s Disease
    Seema V. Patel, Raj J. Shah, Paul D. Coleman, Marwan Noel Sabbagh · 2011 · International Journal of Alzheimer s Disease
  99. Candidate gene analysis for Alzheimer's disease in adults with Down syndrome
    Joseph Hyungwoo Lee, Annie Lee, Lam‐Ha T. Dang, Deborah I. Pang, Sergey Kisselev, Sharon J. Krinsky‐McHale, Warren B. Zigman, Jose Alejandro Luchsinger, Wayne P. Silverman, Benjamin Tycko et al. · 2017 · Neurobiology of Aging
  100. GWAS and Meta-Analysis in Aging/Longevity
    Linda Broer, Cornelia M. van Duijn · 2015 · Advances in experimental medicine and biology